Skip to main content
. 2020 Aug 8;3(3):179–192. doi: 10.1093/abt/tbaa017

Figure 3.

Figure 3

Direct effects of CD47 antibodies on tumor cells. Several CD47 antibodies induce signaling that causes cancer cell death (1F7, AD22, CC2C6, and AO-176) or suppress cancer stem cells (B6H12). In contrast, blocking CD47 in nonmalignant cells preserves stem cells and can be cytoprotective [31, 121].